Injectable collagenase clostridium histolyticum for Dupuytren's contracture. - Wikidata - wikimedia - TriplyDB

Injectable collagenase clostridium histolyticum for Dupuytren's contracture.

Injectable collagenase clostridium histolyticum for Dupuytren's contracture.

http://www.wikidata.org/entity/Q35000980

about

Surgery for Dupuytren's contracture of the fingers Surgery for Dupuytren's contractures of the fingers Noninflammatory Joint Contractures Arising from Immobility: Animal Models to Future Treatments Anti-TNF therapy: past, present and future Structural Comparison of ColH and ColG Collagen-Binding Domains from Clostridium histolyticum Immunity, Inflammation, and Cancer What are we measuring? A critique of range of motion methods currently in use for Dupuytren's disease and recommendations for practice Connective Tissue Degeneration: Mechanisms of Palmar Fascia Degeneration (Dupuytren's Disease)In vitro study of novel collagenase (XIAFLEX®) on Dupuytren's disease fibroblasts displays unique drug related properties Trends in the Treatment of Dupuytren Disease in the United States Between 2007 and 2014.Psychometric evaluation of the Disabilities of the Arm, Shoulder and Hand (DASH) with Dupuytren's contracture: validity evidence using Rasch modeling Nonsurgical treatment of Dupuytren's contracture: 1-year US post-marketing safety data for collagenase clostridium histolyticum.Fibroblasts from phenotypically normal palmar fascia exhibit molecular profiles highly similar to fibroblasts from active disease in Dupuytren's Contracture.Psychometric properties of health-related quality of life instruments in patients undergoing palmar fasciectomy for dupuytren's disease: a prospective study.Difference in Success Treating Proximal Interphalangeal and Metacarpophalangeal Joints with Collagenase: Results of 208 Treatments Reversal of TGF-β1 stimulation of α-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren's-derived fibroblasts.The emerging role of Clostridium histolyticum collagenase in the treatment of Dupuytren disease.Dupuytren's Disease: Review of the Current Literature.Multiple concurrent collagenase clostridium histolyticum injections to Dupuytren's cords: an exploratory study Late complications of clinical clostridium histolyticum collagenase use in Dupuytren's disease Postapproval clinical experience in the treatment of Dupuytren's contracture with collagenase clostridium histolyticum (CCH): the first 1,000 days Anti-fibrotic action of pirfenidone in Dupuytren's disease-derived fibroblasts Genome-wide analysis using exon arrays demonstrates an important role for expression of extra-cellular matrix, fibrotic control and tissue remodelling genes in Dupuytren's disease Prevalence, incidence, and treatments of Dupuytren's disease in the United States: results from a population-based study Use of resources and costs associated with the treatment of Dupuytren's contracture at an orthopedics and traumatology surgery department in Denia (Spain): collagenase clostridium hystolyticum versus subtotal fasciectomy.Cloning of a novel collagenase gene from the gram-negative bacterium Grimontia (Vibrio) hollisae 1706B and its efficient expression in Brevibacillus choshinensis Night-time splinting after fasciectomy or dermo-fasciectomy for Dupuytren's contracture: a pragmatic, multi-centre, randomised controlled trial.Structures of three polycystic kidney disease-like domains from Clostridium histolyticum collagenases ColG and ColH.Collagenase clostridium histolyticum in patients with Dupuytren's contracture: results from POINT X, an open-label study of clinical and patient-reported outcomes.Collagenase treatment of Dupuytren's contracture using a modified injection method: a prospective cohort study of skin tears in 164 hands, including short-term outcome.Developing an animal model of Dupuytren's disease by orthotopic transplantation of human fibroblasts into athymic rat Clinical outcomes following collagenase injections compared to fasciectomy in the treatment of Dupuytren's contracture Modulation of extracellular matrix in cancer is associated with enhanced tumor cell targeting by bacteriophage vectors Clinical Results of Percutaneous Needle Fasciotomy for Dupuytren's Disease in Japanese Patients Assessment of potential cross-reactivity of human endogenous matrix metalloproteinases with collagenase Clostridium histolyticum antibodies in human sera obtained from patients with Dupuytren's contracture.Modified percutaneous needle aponeurotomy for the treatment of dupuytren's contracture: early results and complications.Delayed manipulation after collagenase clostridium histolyticum injection for Dupuytren contracture.RNA sequencing reveals a depletion of collagen targeting microRNAs in Dupuytren's disease.Minimally invasive partial fasciectomy for Dupuytren's contractures.Collagenase Dupuytren Contracture: Achieving Single Treatment Success with a Hand Therapist-Based Protocol.

P2860

Q24187166-D765E218-2F97-405F-8FA0-615D3F317A4D Q24200236-E47C715B-E5CA-479D-B4B3-D38441C29345 Q26801592-3D8856F0-8E6B-473E-893B-86CCC6B55865 Q26997311-A18D0973-FA6F-47E4-A3C6-7C3EF6C79C5B Q27675085-A8AC008C-E5CA-4613-A035-46A92C347869 Q27861048-407C35F0-9E6D-4B4F-9083-E132D368A6C9 Q28067091-9AAA9FD1-25B4-43A6-AA17-7739CF842148 Q28070387-B61D03C8-8F51-4B1B-9556-331C78B22D35 Q28481259-99D34B1E-12C9-4B9B-AA0D-E57D8445403C Q30275011-A1452397-5CB3-4491-9C6F-81B42C4EE8FD Q30597451-F28319BC-4612-4E85-B34F-1344859639ED Q30639252-7266EB8F-DF8A-473A-B2B3-F035EE212839 Q33353493-9BAC5451-47D2-4A22-A1AA-9A23086B4CE7 Q33619753-BD205417-5AAA-4E3F-B1C5-26DC480F3F1A Q33664757-CE107C04-9098-462D-A3E2-CD0B5817AAF3 Q33911834-595A7949-1168-4FBB-B34F-124D4700CCE9 Q34153159-68057CC5-68E0-41E3-9ED4-01BD7912F9C2 Q34212977-5C2A77F7-31AE-42C7-B05F-86A321D66001 Q34249633-42AB057D-0391-40ED-ABCC-5D2940CA3A23 Q34389581-DAAEAE3A-5597-400C-9908-E512F3272675 Q34534536-C2069263-AF43-4B45-A91E-EBB112D41675 Q34544470-39DE4D3B-5413-4DA8-8E59-BD5BAF100BD3 Q34648643-C9C925FE-271E-45D3-8E24-D2EC28513EFC Q34975787-464705EC-CD25-44D9-9282-DD4EA8AA9EA1 Q35017315-6ACA6D26-F112-4653-958D-5923B37B4922 Q35096207-FE838169-F0C2-4E62-841B-0EBB56781392 Q35137482-95D10461-4581-43B8-AE32-4663C146C232 Q35167677-0CDE11ED-BFD0-429E-AD37-CCF88C9996BC Q35181805-3252B2FA-F485-4F62-AA81-D8D0A6AD7343 Q35645333-F3E52FD4-6E00-4282-ABBD-D5FF21D61783 Q35655476-1D38612C-8097-4258-B4F3-C593A0DF1409 Q35661449-2E08C5D7-9850-438E-B99F-0B0817E3E676 Q35672938-062D93EE-212C-476B-95B1-7A317902A201 Q35687675-B5049C61-5E4B-4B07-A49A-5E0DB7DE69A4 Q35867209-35C533D5-E7C7-4FBD-BD20-0E31B0F55BF0 Q36001699-EB961AEC-B033-4793-880A-CBE14AE96768 Q36001782-C36F4030-C465-4662-AE4F-52F9A5C7836C Q36134941-95D0D827-8E4F-42B2-AE03-FF63BA438AFE Q36427744-3864DD28-954D-44B4-A9E6-8BDD0C8CC341 Q36653340-77A401FF-3124-4446-B385-CB25F6E87429

P2860

Injectable collagenase clostridium histolyticum for Dupuytren's contracture.

http://www.wikidata.org/entity/Q35000980

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Injectable collagenase clostridium histolyticum for Dupuytren's contracture.

@ast

Injectable collagenase clostridium histolyticum for Dupuytren's contracture.

@en

type

label

Injectable collagenase clostridium histolyticum for Dupuytren's contracture.

@ast

Injectable collagenase clostridium histolyticum for Dupuytren's contracture.

@en

prefLabel

Injectable collagenase clostridium histolyticum for Dupuytren's contracture.

@ast

Injectable collagenase clostridium histolyticum for Dupuytren's contracture.

@en

P1433

Q35000980-725A403A-DBDB-49B2-96F3-F4C3604D19CE

P1476

Q35000980-AFF45B65-F848-4951-B9DE-48B16BCDCB1A

P2093

Q35000980-42872D5F-59A1-4ECA-BEF6-F800E54E60D9

Q35000980-4F0D44EF-D812-4121-8BDE-5F67571BF6BE

Q35000980-829B53BD-835B-4892-8964-FDC8E8576DA5

Q35000980-A5B77E97-C743-4C12-8A8C-5EEA65A40E9F

Q35000980-B80D3D3D-EE9C-41E6-889B-5435E7192D7B

Q35000980-C63F00D7-B55F-434E-93F9-3D69497576E7

Q35000980-D5C1E2F1-52C4-4F7A-B038-E7E83034B5E9

Q35000980-F4964D25-56A6-4AA0-AC0B-D4D98BA71CFF

Q35000980-FC4B836D-C538-4CF1-A261-DB55E71F2C29

P304

Q35000980-086D7062-AD24-4967-A1E6-F236D7063CC7

P31

Q35000980-BE274367-416A-4FD8-9477-23BA8BADDC59

P356

Q35000980-EE5F2578-95DE-480B-9317-99D00FE41B6C

P407

Q35000980-B34B8911-79FE-4EF7-A1B3-805EEA35BEA8

P433

Q35000980-60CA7AEF-8407-40C5-9BEE-EB46BA294F26

P478

Q35000980-846BD998-C74F-41B2-B980-658009437AF1

P577

Q35000980-761FE11A-DF43-4302-B366-970E32F27F8A

P698

Q35000980-FA884769-6818-44CF-87DA-5D7FAD806B9F

P356

P1433

The New England Journal of Medicine

P1476

Injectable collagenase clostridium histolyticum for Dupuytren's contracture.

@en

P2093

CORD I Study Group

http://www.w3.org/2001/XMLSchema#string

F Thomas D Kaplan

http://www.w3.org/2001/XMLSchema#string

John Rodzvilla

http://www.w3.org/2001/XMLSchema#string

Lawrence C Hurst

http://www.w3.org/2001/XMLSchema#string

Marie A Badalamente

http://www.w3.org/2001/XMLSchema#string

Robert N Hotchkiss

http://www.w3.org/2001/XMLSchema#string

Roy A Meals

http://www.w3.org/2001/XMLSchema#string

Theodore M Smith

http://www.w3.org/2001/XMLSchema#string

Vincent R Hentz

http://www.w3.org/2001/XMLSchema#string

P304

968-979

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA0810866

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

361

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19726771

http://www.w3.org/2001/XMLSchema#string